Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DNQX (FG 9041) is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors, respectively)
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 12,000 | |||
50 mg | 在庫あり | ¥ 19,000 | |||
100 mg | 在庫あり | ¥ 27,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | DNQX (FG 9041) is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors, respectively) |
In vitro | DNQX has been used to specifically target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors. DNQX does not stimulate a robust long-term potentiation in the hippocampus[1] |
別名 | FG 9041 |
分子量 | 252.14 |
分子式 | C8H4N4O6 |
CAS No. | 2379-57-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 35 mg/mL (138.81 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DNQX 2379-57-9 Membrane transporter/Ion channel Neuroscience iGluR GluR inhibit nucleus selective thalamic Ionotropic glutamate receptors FG 9041 Inhibitor quinoxaline FG9041 non-NMDA competitive reticular FG-9041 inhibitor